Evaluation of an oral bedaquiline regimen for treating multidrug-resistant TB in China: a randomized trial

Key Points

• The study aims to evaluate the effectiveness of an oral bedaquiline regimen for treating multidrug-resistant tuberculosis (TB) in China.
• Randomized trial design
• Investigated an oral regimen of bedaquiline
• Focused on multidrug-resistant TB cases
• Conducted in multiple clinical settings
• Oral bedaquiline demonstrated improved treatment outcomes
• Participants exhibited higher recovery rates
• Reduced side effects compared to traditional therapies